Written based on 4 research studies on PubMed, searched on 14 Nov 2026.
The claim
Posts online say that curcumin (turmeric) helps with congenital heart disease.
Where research stands
We found 4 published papers on curcumin (turmeric) and congenital heart disease. They were published between 2012 and 2020. None of them is a study in people. 1 was a study in animals, and 1 was only in cells in the lab.
- 0In people
- 1In animals
- 1Only in the lab
What the studies found
We have not summed up these studies in words yet. The most important papers are listed under Sources.
Verdict
Curcumin (turmeric) has been studied for congenital heart disease in animals, not yet in people.
Unproven means: it was only tested in animals or cells, or there is too little or mixed data from people. How we rate claims
What this means for you: Results in animals or in cells often do not hold in people. Do not stop or change your medicines because of it. Ask your doctor before you start taking it.
Sources
- Curcumin-mediated cardiac defects in mouse is associated with a reduced histone H3 acetylation and reduced expression of cardiac transcription factors.2014 · Cardiovasc Toxicol · In animals
- Inhibition of histone acetylation by curcumin reduces alcohol-induced expression of heart development-related transcription factors in cardiac progenitor cells.2012 · Biochem Biophys Res Commun · In the lab
- Curcumin inhibits calcification of human aortic valve interstitial cells by interfering NF-κB, AKT, and ERK pathways.2020 · Phytother Res · Other paper
- The role of curcumin as an inhibitor of oxidative stress caused by ischaemia re-perfusion injury in tetralogy of Fallot patients undergoing corrective surgery.2016 · Cardiol Young · Other paper
